Diseases, Conditions, Syndromes

UK virus hunting labs seek to bolster global variant network

The air conditioners hum constantly in the lab at the Wellcome Sanger Institute, countering the heat thrown off by rows of high-tech sequencing machines that work seven days a week analyzing the genetic material of COVID-19 ...

Medical economics

German vaccine maker CureVac surges almost 250% in Nasdaq debut

Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.

Vaccination

Moderna has no plans to share its COVID-19 vaccine recipe

Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company's own production is the best way to increase the global supply, the company's chairman said Monday.

Medications

Novartis generics unit Sandoz makes stock market debut

Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.

Diseases, Conditions, Syndromes

Germany enlists Fitbits and smartwatches in virus battle

Germany's centre for disease control on Tuesday urged people with smartwatches and fitness bands to share their health data to help keep track of the spread of the coronavirus.

page 3 from 20